Delivery Order SPE2DB22D1002-SPE2DB25FLBE6
Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,851.91 to AmerisourceBergen Drug Corp for VERQUVO 2.5 mg tablets (30-count supply) on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a small-value pharmaceutical transaction within the company's broader federal contract portfolio. The award will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,849.00 delivery order to AmerisourceBergen Drug Corp for VERQUVO 2.5 mg tablets (30 count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $2,310.12 to AmerisourceBergen Drug Corp for VERQUVO 5 MG tablets (100-count unit dose packaging) with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order, awarded on July 23, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Verquvo 10 mg tablets (quantity 90) at a firm fixed price of $12,569.21, with completion targeted for September 3, 2025. This contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Verquvo 10 mg tablets (30-count units) with a ceiling value of $2,449.20. This firm fixed price delivery order, set to be completed by September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Verquvo 5 mg tablets (14-count units) valued at $2,415.96, with completion scheduled for September 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a fulfillment under AmerisourceBergen's existing pharmaceutical supply contract vehicle. The product will be performed at the company's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,227.26 to AmerisourceBergen Drug Corp for the supply of Verquvo 10 mg tablets (30-count packaging). The award, made on July 8, 2025, with an ultimate completion date of July 9, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- This federal contract award, valued at $2,854.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VERQUVO 5 MG TABLET 30S, a pharmaceutical product, and has an ultimate completion date of June 10, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The contract was not designated with a set-aside requirement, indicating open...
- This delivery order awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at $1,049.21 for the supply of Verquvo 2.5 mg tablets (30-count) under a competitive, non-set-aside procurement. The Defense Logistics Agency, which manages pharmaceutical supply chains for the Department of Defense, issued this award with an ultimate completion date of August 8, 2025. The contractor will perform this delivery from its corporate office in Conshohocken, Pennsylvania, where...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VERQUVO 5 MG Tablets. The $1,041.29 order is for pharmaceutical products to be delivered to a location in Conshohocken, Pennsylvania by December 26, 2023. As a prime contractor, Amerisourcebergen Drug Corp has a history of supplying pharmaceuticals, medical supplies, and related distribution services to support DLA...